Medicaid insurance policies differ from state-to-state. With the arrival of latest, GLP-1 drugs (and others) to deal with weight problems and obese, there are probably vital well being advantages to be gained. However, are State Medicaid Agencies really masking these drugs? This is the query requested by Liu et al. (2024). They use knowledge from public state Medicaid formulary and most popular drug checklist recordsdata to find out if a state coated FDA-approved anti-obesity drugs. The variety of reimbursed prescriptions for every antiobesity remedy was recognized from public 2011-2022 Medicaid State Drug Utilization knowledge.
In basic, some however not all anti-obesity drugs are coated. Moreover, the simpler GLP-1 drugs are sometimes solely coated if they’re used to deal with diabetes (reasonably than obese or weight problems).
In the primary quarter of 2023, 10 of 47 states (21%) with public most popular drug lists coated at the very least 1 antiobesity remedy; 5 (11%) had unrestricted protection of at the very least 1 antiobesity remedy…Separately, 39 states (83%) had unrestricted protection of at the very least 1 of the two diabetes variations of GLP-1 RAs.
The full article is right here.